{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T16:56:23Z","timestamp":1791305783761,"version":"4.3.1"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T00:00:00Z","timestamp":1644796800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s10787-022-00926-y","type":"journal-article","created":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T19:02:57Z","timestamp":1644865377000},"page":"369-383","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Effect of statins on the plasma\/serum levels of inflammatory markers in patients with cardiovascular disease; a systematic review and meta-analysis of randomized clinical trials"],"prefix":"10.1007","volume":"30","author":[{"given":"Mitra","family":"Abbasifard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahmineh","family":"Kandelouei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahman","family":"Razi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyal","family":"Imani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahdieh","family":"Fasihi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4367-3884","authenticated-orcid":false,"given":"F. G.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,14]]},"reference":[{"key":"926_CR1","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.tcm.2018.09.017","volume":"29","author":"F Abdolmaleki","year":"2019","unstructured":"Abdolmaleki F, Hayat SMG, Bianconi V, Johnston TP, Sahebkar A (2019) Atherosclerosis and immunity: a perspective. Trends Cardiovasc Med 29:363\u2013371","journal-title":"Trends Cardiovasc Med"},{"key":"926_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.clinthera.2011.11.002","volume":"34","author":"E Abulhul","year":"2012","unstructured":"Abulhul E, McDonald K, Martos R, Phelan D, Spiers JP, Hennessy M, Baugh J, Watson C, O\u2019Loughlin C, Ledwidge MJCT (2012) Long-term statin therapy in patients with systolic heart failure and normal cholesterol: effects on elevated serum markers of collagen turnover, inflammation, and B-type natriuretic peptide. Clin Ther 34:91\u2013100","journal-title":"Clin Ther"},{"key":"926_CR3","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1093\/cvr\/cvaa314","volume":"117","author":"R Ad\u00e3o","year":"2021","unstructured":"Ad\u00e3o R, Ait-Oufella H (2021) Scientists on the Spot: Inflammation in atherosclerosis. Cardiovasc Res 117:e7\u2013e8","journal-title":"Cardiovasc Res"},{"key":"926_CR4","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1093\/icvts\/ivx172","volume":"25","author":"J An","year":"2017","unstructured":"An J, Shi F, Liu S, Ma J, Ma Q (2017) Preoperative statins as modifiers of cardiac and inflammatory outcomes following coronary artery bypass graft surgery: a meta-analysis. Interact Cardiovasc Thorac Surg 25:958\u2013965","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"926_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2009.10.046","volume":"210","author":"I Andreou","year":"2010","unstructured":"Andreou I, Tousoulis D, Miliou A, Tentolouris C, Zisimos K, Gounari P, Siasos G, Papageorgiou N, Papadimitriou CA, Dimopoulos M-AJA (2010) Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study. Atherosclerosis 210:194\u2013198","journal-title":"Atherosclerosis"},{"key":"926_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1080\/07853890.2016.1197413","volume":"48","author":"JC Ar\u00e9valo-lorido","year":"2016","unstructured":"Ar\u00e9valo-lorido JC (2016) Clinical relevance for lowering C-reactive protein with statins. Ann Med 48:516\u2013524","journal-title":"Ann Med"},{"key":"926_CR7","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.amjcard.2004.08.093","volume":"95","author":"RR Azar","year":"2005","unstructured":"Azar RR, Badaoui G, Sarkis A, Kassab R, Salam\u00e9 E, Klaym\u00e9 S, Naman R, Germanos MJTAJOC (2005) Effects of tirofiban and statins on high-sensitivity C-reactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery disease. Am J Cardiol 95:236\u2013240","journal-title":"Am J Cardiol"},{"key":"926_CR8","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.phrs.2018.08.014","volume":"135","author":"A Bahrami","year":"2018","unstructured":"Bahrami A, Parsamanesh N, Atkin SL, Banach M, Sahebkar A (2018) Effect of statins on toll-like receptors: a new insight to pleiotropic effects. Pharmacol Res 135:230\u2013238","journal-title":"Pharmacol Res"},{"key":"926_CR9","doi-asserted-by":"crossref","unstructured":"Bahrami A, Bo S, Jamialahmadi T, Sahebkar A (2020) Effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors on ageing: molecular mechanisms. Ageing Res Rev 58","DOI":"10.1016\/j.arr.2020.101024"},{"key":"926_CR10","doi-asserted-by":"publisher","first-page":"670","DOI":"10.7326\/0003-4819-139-8-200310210-00011","volume":"139","author":"EM Balk","year":"2003","unstructured":"Balk EM, Lau J, Goudas LC, Jordan HS, Kupelnick B, Kim LU, Karas RH (2003) Effects of statins on nonlipid serum markers associated with cardiovascular disease: a systematic review. Ann Intern Med 139:670\u2013682","journal-title":"Ann Intern Med"},{"key":"926_CR11","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.2307\/2533446","volume":"50","author":"CB Begg","year":"1994","unstructured":"Begg CB, Mazumdar MJB (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088\u20131101","journal-title":"Biometrics"},{"key":"926_CR12","first-page":"491","volume":"8","author":"E Climent","year":"2021","unstructured":"Climent E, Benaiges D, Pedro-Botet JJFICM (2021) Hydrophilic or lipophilic statins? Frontier Cardiovasc Med 8:491","journal-title":"Frontier Cardiovasc Med"},{"key":"926_CR13","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","volume":"7","author":"R Dersimonian","year":"1986","unstructured":"Dersimonian R, Laird NJCCT (1986) Meta-analysis in clinical trials. Control Clin Trial 7:177\u2013188","journal-title":"Control Clin Trial"},{"key":"926_CR14","doi-asserted-by":"publisher","first-page":"718","DOI":"10.37358\/RC.19.2.6992","volume":"70","author":"LC Dima-Cozma","year":"2019","unstructured":"Dima-Cozma LC, Cozma S, Hinganu D, Ghiciuc CM, Mitu F (2019) Targeting matrix metalloproteinases in atherosclerosis and cardiovascular dysfunction. Rev Chim 70:718\u2013720","journal-title":"Rev Chim"},{"key":"926_CR15","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.21037\/apm-20-925","volume":"9","author":"S Ding","year":"2020","unstructured":"Ding S, Xu S, Chen X, Wu SJAOPM (2020) Effects of atorvastatin combined with bivalirudin on coagulation function, cardiac function, and inflammatory factors of percutaneous coronary intervention in elderly patients with acute myocardial infarction. Ann Palliat Med 9:1905\u20131911","journal-title":"Ann Palliat Med"},{"key":"926_CR16","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/clc.4960280206","volume":"28","author":"YC Doo","year":"2005","unstructured":"Doo YC, Han SJ, Han SW, Park WJ, Choi SH, Cho GY, Hong KS, Han KR, Lee NH, Oh DJJCCAII, Disease PRJFAITTOC (2005) Effect of preexisting statin use on expression of C-reactive protein, adhesion molecules, interleukin-6, and antioxidized low-density lipoprotein antibody in patients with unstable angina undergoing coronary stenting. Clin Cardiol 28:72\u201376","journal-title":"Clin Cardiol"},{"key":"926_CR17","doi-asserted-by":"publisher","first-page":"199","DOI":"10.20538\/1682-0363-2018-4-199-207","volume":"17","author":"V Dutova","year":"2018","unstructured":"Dutova V, Saranchina J, Karpova M, Kilina OY, Polshcha N, Kulakova T, Khanarin N (2018) Cytokines and atherosclerosis\u2014new research directions. Bull Siber Med 17:199\u2013208","journal-title":"Bull Siber Med"},{"key":"926_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","volume":"315","author":"M Egger","year":"1997","unstructured":"Egger M, Smith GD, Schneider M, Minder CJB (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629\u2013634","journal-title":"BMJ"},{"key":"926_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-53238-7","volume":"9","author":"P Eliasson","year":"2019","unstructured":"Eliasson P, Dietrich-Zagonel F, Lundin A-C, Aspenberg P, Wolk A, Micha\u00eblsson KJSR (2019) Statin treatment increases the clinical risk of tendinopathy through matrix metalloproteinase release\u2013a cohort study design combined with an experimental study. Sci Rep 9:1\u201311","journal-title":"Sci Rep"},{"key":"926_CR20","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.plipres.2015.08.003","volume":"60","author":"G Ferretti","year":"2015","unstructured":"Ferretti G, Bacchetti T, Sahebkar A (2015) Effect of statin therapy on paraoxonase-1 status: a systematic review and meta-analysis of 25 clinical trials. Prog Lipid Res 60:50\u201373","journal-title":"Prog Lipid Res"},{"key":"926_CR21","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3390\/cells10020226","volume":"10","author":"S Gencer","year":"2021","unstructured":"Gencer S, Evans BR, van der Vorst EP, D\u00f6ring Y, Weber C (2021) Inflammatory chemokines in atherosclerosis. Cells 10:226","journal-title":"Cells"},{"key":"926_CR22","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1007\/s10741-020-09929-9","volume":"26","author":"AM Gorabi","year":"2021","unstructured":"Gorabi AM, Kiaie N, Pirro M, Bianconi V, Jamialahmadi T, Sahebkar A (2021) Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications. Heart Fail Rev 26:1259\u20131272","journal-title":"Heart Fail Rev"},{"key":"926_CR23","doi-asserted-by":"publisher","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","volume":"73","author":"SM Grundy","year":"2019","unstructured":"Grundy SM, Stone NJ, Bailey AL, Beam C, Birtcher KK, Blumenthal RS, Braun LT, de Ferranti S, Faiella-Tommasino J, Forman DEJJOTACOC (2019) 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines. J Am Col Cardiol 73:3168\u20133209","journal-title":"J Am Col Cardiol"},{"key":"926_CR24","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","volume":"21","author":"JP Higgins","year":"2002","unstructured":"Higgins JP, Thompson SGJSIM (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539\u20131558","journal-title":"Stat Med"},{"key":"926_CR25","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1093\/clinchem\/hvaa252","volume":"67","author":"RC Hoogeveen","year":"2021","unstructured":"Hoogeveen RC, Ballantyne CM (2021) Residual cardiovascular risk at low LDL: remnants, lipoprotein(a), and inflammation. Clin Chem 67:143\u2013153","journal-title":"Clin Chem"},{"key":"926_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJM, Gavaghan DJ, McQuay HJJCCT (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trial 17:1\u201312","journal-title":"Control Clin Trial"},{"key":"926_CR27","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.5114\/aoms\/141155","volume":"17","author":"M Khalifeh","year":"2021","unstructured":"Khalifeh M, Penson PE, Banach M, Sahebkar A (2021) Statins as anti-pyroptotic agents. Arch Med Sci 17:1414\u20131417","journal-title":"Arch Med Sci"},{"key":"926_CR28","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1161\/01.CIR.0000091404.09558.AF","volume":"108","author":"S Kinlay","year":"2003","unstructured":"Kinlay S, Schwartz GG, Olsson AG, Rifai N, Leslie SJ, Sasiela WJ, Szarek M, Libby P, Ganz PJC (2003) High-dose atorvastatin enhances the decline in inflammatory markers in patients with acute coronary syndromes in the MIRACL study. Circulation 108:1560\u20131566","journal-title":"Circulation"},{"key":"926_CR29","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1161\/01.ATV.0000030997.02059.BB","volume":"22","author":"KK Koh","year":"2002","unstructured":"Koh KK, Son JW, Ahn JY, Jin DK, Kim HS, Choi YM, Kim DS, Jeong E-M, Park GS, Choi ISJA, THROMBOSIS, & BIOLOGY, V (2002) Comparative effects of diet and statin on no bioactivity and matrix metalloproteinases in hypercholesterolemic patients with coronary artery disease. Arterioscler Thromb Vasc Biol 22:e19\u2013e23","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"926_CR30","first-page":"357","volume":"15","author":"M Lewandowski","year":"2008","unstructured":"Lewandowski M, Kornacewicz-Jach Z, Millo B, Zielonka J, Czechowska M, Kaliszczak R, P\u0142o\u0144ska E, Gor\u0105cy J, Ka\u017amierczak J, Naruszewicz MJCJ (2008) The influence of low dose atorvastatin on inflammatory marker levels in patients with acute coronary syndrome and its potential clinical value. Cardiol J 15:357\u2013364","journal-title":"Cardiol J"},{"key":"926_CR31","doi-asserted-by":"publisher","first-page":"105735","DOI":"10.1016\/j.biocel.2020.105735","volume":"122","author":"L Liberale","year":"2020","unstructured":"Liberale L, Carbone F, Montecucco F, Sahebkar A (2020) Statins reduce vascular inflammation in atherogenesis: a review of underlying molecular mechanisms. Int J Biochem Cell Biol 122:105735","journal-title":"Int J Biochem Cell Biol"},{"key":"926_CR32","doi-asserted-by":"publisher","first-page":"2945","DOI":"10.1093\/eurheartj\/ehl277","volume":"27","author":"A Link","year":"2006","unstructured":"Link A, Ayadhi T, B\u00f6hm M, Nickenig GJEHJ (2006) Rapid immunomodulation by rosuvastatin in patients with acute coronary syndrome. Eur Heat J 27:2945\u20132955","journal-title":"Eur Heat J"},{"key":"926_CR33","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.amjcard.2009.07.055","volume":"104","author":"MJ Lipinski","year":"2009","unstructured":"Lipinski MJ, Cauthen CA, Biondi-Zoccai GG, Abbate A, Vrtovec B, Khan BV, Vetrovec GW (2009) Meta-analysis of randomized controlled trials of statins versus placebo in patients with heart failure. Am J Cardiol 104:1708\u20131716","journal-title":"Am J Cardiol"},{"key":"926_CR34","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s00380-004-0776-6","volume":"19","author":"Y Luo","year":"2004","unstructured":"Luo Y, Jiang D, Wen D, Yang J, Li LJH, VESSELS, (2004) Changes in serum interleukin-6 and high-sensitivity C-reactive protein levels in patients with acute coronary syndrome and their responses to simvastatin. Heart Vessel 19:257\u2013262","journal-title":"Heart Vessel"},{"key":"926_CR35","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijcard.2005.01.042","volume":"106","author":"P Marschang","year":"2006","unstructured":"Marschang P, Friedrich GJ, Ditlbacher H, Stoeger A, Zur Nedden D, Kirchmair R, Dienstl A, Pachinger O, Patsch JRJIJOC (2006) Reduction of soluble P-selectin by statins is inversely correlated with the progression of coronary artery disease. Int J Cardiol 106:183\u2013190","journal-title":"Int J Cardiol"},{"key":"926_CR36","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Med PGJP (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Plos Med 6:e1000097","journal-title":"Plos Med"},{"key":"926_CR37","doi-asserted-by":"crossref","unstructured":"Nakagomi A, Seino Y, Kohashi K, Kosugi M, Endoh Y, Kusama Y, Atarashi H, Mizuno KJCJ (2012) Effects of statin therapy on the production of monocyte pro-inflammatory cytokines, cardiac function, and long-term prognosis in chronic heart failure patients with dyslipidemia. CJ-11-1123","DOI":"10.1253\/circj.CJ-11-1123"},{"key":"926_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1080\/14728214.2021.2009801","volume":"26","author":"AJ Nelson","year":"2021","unstructured":"Nelson AJ, Bubb K, Nicholls SJ (2021) An update on emerging drugs for the treatment of hypercholesterolemia. Expert Opin Emerg Drugs 26:363\u2013369","journal-title":"Expert Opin Emerg Drugs"},{"key":"926_CR39","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1023\/A:1023499727477","volume":"246","author":"P Ostadal","year":"2003","unstructured":"Ostadal P, Alan D, Hajek P, Horak D, Vejvoda J, Trefanec J, Mates M, Vojacek JJM, Biochemistry C (2003) The effect of early treatment by cerivastatin on the serum level of C-reactive protein, interleukin-6, and interleukin-8 in patients with unstable angina and non-Q-wave myocadial infarction. Mol Cell Biochem 246:45\u201350","journal-title":"Mol Cell Biochem"},{"key":"926_CR40","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11745-010-3517-x","volume":"46","author":"SMR Parizadeh","year":"2011","unstructured":"Parizadeh SMR, Azarpazhooh MR, Moohebati M, Nematy M, Ghayour-Mobarhan M, Tavallaie S, Rahsepar AA, Amini M, Sahebkar A, Mohammadi M, Ferns GAA (2011) Simvastatin therapy reduces prooxidant-antioxidant balance: Results of a placebo-controlled cross-over trial. Lipids 46:333\u2013340","journal-title":"Lipids"},{"key":"926_CR41","doi-asserted-by":"publisher","first-page":"490","DOI":"10.5114\/aoms.2020.94655","volume":"16","author":"\u017d Reiner","year":"2020","unstructured":"Reiner \u017d, Hatamipour M, Banach M, Pirro M, Al-Rasadi K, Jamialahmadi T, Radenkovic D, Montecucco F, Sahebkar A (2020) Statins and the Covid-19 main protease: In silico evidence on direct interaction. Arch Med Sci 16:490\u2013496","journal-title":"Arch Med Sci"},{"key":"926_CR42","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1016\/j.clinthera.2013.06.019","volume":"35","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Watts GF (2013a) New LDL-cholesterol lowering therapies: Pharmacology, clinical trials, and relevance to acute coronary syndromes. Clin Ther 35:1082\u20131098","journal-title":"Clin Ther"},{"key":"926_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s10557-013-6479-4","volume":"27","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Watts GF (2013b) New therapies targeting apoB metabolism for high-risk patients with inherited dyslipidaemias: what can the clinician expect? Cardiovasc Drugs Ther 27:559\u2013567","journal-title":"Cardiovasc Drugs Ther"},{"key":"926_CR44","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1160\/TH14-11-0937","volume":"114","author":"A Sahebkar","year":"2015","unstructured":"Sahebkar A, Serban C, Mikhailidis DP, Undas A, Lip GYH, Muntner P, Bittner V, Ray KK, Watts GF, Hovingh GK, Rysz J, Kastelein JJP, Banach M (2015) Association between statin use and plasma d-dimer levels: a systematic review and meta-analysis of randomised controlled trials. Thromb Haemost 114:546\u2013557","journal-title":"Thromb Haemost"},{"key":"926_CR45","doi-asserted-by":"publisher","first-page":"1432","DOI":"10.5114\/aoms.2020.100304","volume":"16","author":"N Shakour","year":"2020","unstructured":"Shakour N, Ruscica M, Hadizadeh F, Cirtori C, Banach M, Jamialahmadi T, Sahebkar A (2020) Statins and C-reactive protein: in silico evidence on direct interaction. Arch Med Sci 16:1432\u20131439","journal-title":"Arch Med Sci"},{"key":"926_CR46","doi-asserted-by":"publisher","first-page":"6425","DOI":"10.1002\/jcp.26429","volume":"233","author":"A Shapouri-Moghaddam","year":"2018","unstructured":"Shapouri-Moghaddam A, Mohammadian S, Vazini H, Taghadosi M, Esmaeili SA, Mardani F, Seifi B, Mohammadi A, Afshari JT, Sahebkar A (2018) Macrophage plasticity, polarization, and function in health and disease. J Cell Physiol 233:6425\u20136440","journal-title":"J Cell Physiol"},{"key":"926_CR47","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1016\/j.autrev.2010.07.016","volume":"9","author":"S Sitia","year":"2010","unstructured":"Sitia S, Tomasoni L, Atzeni F, Ambrosio G, Cordiano C, Catapano A, Tramontana S, Perticone F, Naccarato P, Camici P (2010) From endothelial dysfunction to atherosclerosis. Autoimmun Rev 9:830\u2013834","journal-title":"Autoimmun Rev"},{"key":"926_CR48","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.5114\/aoms.2019.89330","volume":"17","author":"SM Sohrevardi","year":"2021","unstructured":"Sohrevardi SM, Nasab FS, Mirjalili MR, Bagherniya M, Tafti AD, Jarrahzadeh MH, Azarpazhooh MR, Saeidmanesh M, Banach M, Jamialahmadi T, Sahebkar A (2021) Effect of atorvastatin on delirium status of patients in the intensive care unit: A randomized controlled trial. Arch Med Sci 17:1423","journal-title":"Arch Med Sci"},{"key":"926_CR49","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.jacc.2005.06.088","volume":"47","author":"S Sola","year":"2006","unstructured":"Sola S, Mir MQ, Khan BV, Lerakis S, Tandon NJJOTACOC (2006) Atorvastatin improves left ventricular systolic function and serum markers of inflammation in nonischemic heart failure. J Am Coll Cardiol 47:332\u2013337","journal-title":"J Am Coll Cardiol"},{"key":"926_CR50","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ijcard.2007.11.025","volume":"133","author":"E Stefanadi","year":"2009","unstructured":"Stefanadi E, Tousoulis D, Antoniades C, Katsi V, Bosinakou E, Vavuranakis E, Triantafyllou G, Marinou K, Tsioufis C, Papageorgiou NJIJOC (2009) Early initiation of low-dose atorvastatin treatment after an acute ST-elevated myocardial infarction, decreases inflammatory process and prevents endothelial injury and activation. Int J Cardiol 133:266\u2013268","journal-title":"Int J Cardiol"},{"key":"926_CR51","doi-asserted-by":"publisher","first-page":"2311","DOI":"10.1161\/ATVBAHA.108.179697","volume":"30","author":"D Steinberg","year":"2010","unstructured":"Steinberg D, Witztum JL (2010) Oxidized low-density lipoprotein and atherosclerosis. Arterioscler Thromb Vasc Biol 30:2311\u20132316","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"926_CR52","first-page":"347","volume":"7","author":"ID Strazhesko","year":"2016","unstructured":"Strazhesko ID, Tkacheva ON, Akasheva DU, Dudinskaya EN, Plokhova EV, Pykhtina VS, Kruglikova AS, Kokshagina NV, Sharashkina NV, Agaltsov MVJFIP (2016) Atorvastatin therapy modulates telomerase activity in patients free of atherosclerotic cardiovascular diseases. Frontier Pharmacol 7:347","journal-title":"Frontier Pharmacol"},{"key":"926_CR53","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.phrs.2018.12.010","volume":"141","author":"R Tabrizi","year":"2019","unstructured":"Tabrizi R, Tamtaji OR, Mirhosseini N, Lankarani KB, Akbari M, Dadgostar E, Borhani-Haghighi A, Peymani P, Ahmadizar F, Asemi Z (2019) The effects of statin use on inflammatory markers among patients with metabolic syndrome and related disorders: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 141:85\u2013103","journal-title":"Pharmacol Res"},{"key":"926_CR54","doi-asserted-by":"publisher","first-page":"3165","DOI":"10.2174\/1381612825666190830153056","volume":"25","author":"E Taghizadeh","year":"2019","unstructured":"Taghizadeh E, Taheri F, Renani PG, Reiner \u017d, Navashenaq JG, Sahebkar A (2019) Macrophage: a key therapeutic target in atherosclerosis? Curr Pharm Des 25:3165\u20133174","journal-title":"Curr Pharm Des"},{"key":"926_CR55","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.atherosclerosis.2004.08.037","volume":"178","author":"D Tousoulis","year":"2005","unstructured":"Tousoulis D, Antoniades C, Bosinakou E, Kotsopoulou M, Pitsavos C, Vlachopoulos C, Panagiotakos D, Stefanadis CJA (2005a) Effects of atorvastatin on reactive hyperemia and inflammatory process in patients with congestive heart failure. Atherosclerosis 178:359\u2013363","journal-title":"Atherosclerosis"},{"key":"926_CR56","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.1016\/j.ejheart.2005.03.007","volume":"7","author":"D Tousoulis","year":"2005","unstructured":"Tousoulis D, Antoniades C, Vassiliadou C, Toutouza M, Pitsavos C, Tentolouris C, Trikas A, Stefanadis CJEJOHF (2005b) Effects of combined administration of low dose atorvastatin and vitamin e on inflammatory markers and endothelial function in patients with heart failure. Eur J Heart Fail 7:1126\u20131132","journal-title":"Eur J Heart Fail"},{"key":"926_CR57","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","volume":"37","author":"D Tousoulis","year":"2016","unstructured":"Tousoulis D, Oikonomou E, Economou EK, Crea F, Kaski JC (2016) Inflammatory cytokines in atherosclerosis: current therapeutic approaches. Eur Heart J 37:1723\u20131732","journal-title":"Eur Heart J"},{"key":"926_CR58","doi-asserted-by":"publisher","first-page":"579","DOI":"10.5114\/aoms\/132950","volume":"17","author":"A Vahedian-Azimi","year":"2021","unstructured":"Vahedian-Azimi A, Mohammadi SM, Beni FH, Banach M, Guest PC, Jamialahmadi T, Sahebkar A (2021) Improved COVID-19 ICU admission and mortality outcomes following treatment with statins: a systematic review and meta-analysis. Arch Med Sci 17:579\u2013595","journal-title":"Arch Med Sci"},{"key":"926_CR59","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1177\/1074248412474346","volume":"18","author":"Z Wang","year":"2013","unstructured":"Wang Z, Dai H, Xing M, Yu Z, Lin X, Wang S, Zhang J, Hou F, Ma Y, Ren YJJOCP (2013) Effect of a single high loading dose of rosuvastatin on percutaneous coronary intervention for acute coronary syndromes. J Cardiovasc Ther Pharmacol Ther 18:327\u2013333","journal-title":"J Cardiovasc Ther Pharmacol Ther"},{"key":"926_CR60","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/1755-5922.12098","volume":"32","author":"W Xie","year":"2014","unstructured":"Xie W, Li P, Wang Z, Chen J, Lin Z, Liang X, Mo YJCT (2014) Rosuvastatin may reduce the incidence of cardiovascular events in patients with acute coronary syndromes receiving percutaneous coronary intervention by suppressing miR-155\/SHIP-1 signaling pathway. Cardiovasc Ther 32:276\u2013282","journal-title":"Cardiovasc Ther"},{"key":"926_CR61","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cca.2005.12.029","volume":"368","author":"J Yang","year":"2006","unstructured":"Yang J, Li X-P, Zhao S-P, Li J, Li J-D, Xie X-MJCCA (2006) The effect of different doses of fluvastatin on inflammatory markers in the early phase of acute coronary syndrome. Clin Chim Acta 368:183\u2013187","journal-title":"Clin Chim Acta"},{"key":"926_CR62","doi-asserted-by":"publisher","first-page":"467","DOI":"10.2174\/138161209787315684","volume":"15","author":"Q Zhou","year":"2009","unstructured":"Zhou Q, Liao JK (2009) Statins and cardiovascular diseases: from cholesterol lowering to pleiotropy. Curr Pharm Des 15:467\u2013478","journal-title":"Curr Pharm Des"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-022-00926-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-022-00926-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T03:46:02Z","timestamp":1666496762000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-022-00926-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,14]]},"references-count":62,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["926"],"URL":"https:\/\/doi.org\/10.1007\/s10787-022-00926-y","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"value":"0925-4692","type":"print"},{"value":"1568-5608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,14]]},"assertion":[{"value":"4 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}